Literature DB >> 23966173

Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiation.

Marie-jo Halaby1, Razqallah Hakem, Anne Hakem.   

Abstract

Ubiquitylation is currently recognized as a major posttranslational modification that regulates diverse cellular processes. Pirh2 is a ubiquitin E3 ligase that regulates the turnover and functionality of several proteins involved in cell proliferation and differentiation, cell cycle checkpoints, and cell death. Here we review the role of Pirh2 as a regulator of the DNA damage response through the ubiquitylation of p53, Chk2, p73, and PolH. By ubiquitylating these proteins, Pirh2 regulates cell cycle checkpoints and cell death in response to DNA double-strand breaks or the formation of bulky DNA lesions. We also discuss how Pirh2 affects cell proliferation and differentiation in unstressed conditions through ubiquitylation and degradation of c-Myc, p63, and p27(kip1). Finally, we link these different functions of Pirh2 to its role as a tumor suppressor in mice and as a prognosis marker in various human cancer subtypes.

Entities:  

Keywords:  Chk2; Pirh2; c-Myc; p27Kip1; p53; p63; p73; polH; ubiquitylation

Mesh:

Substances:

Year:  2013        PMID: 23966173      PMCID: PMC3899186          DOI: 10.4161/cc.25785

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response.

Authors:  Dong Zhang; Kathrin Zaugg; Tak W Mak; Stephen J Elledge
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

2.  Monoubiquitylation promotes mitochondrial p53 translocation.

Authors:  Natasha D Marchenko; Sonja Wolff; Susan Erster; Kerstin Becker; Ute M Moll
Journal:  EMBO J       Date:  2007-02-01       Impact factor: 11.598

3.  Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456.

Authors:  Elizabeth M Kass; Jinwoo Ahn; Tomoaki Tanaka; William A Freed-Pastor; Susan Keezer; Carol Prives
Journal:  J Biol Chem       Date:  2007-08-21       Impact factor: 5.157

Review 4.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.

Authors:  Isabel M Chu; Ludger Hengst; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716

Review 5.  CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?

Authors:  Laurent Antoni; Nayanta Sodha; Ian Collins; Michelle D Garrett
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

6.  Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Takayuki Hattori; Tomoyasu Isobe; Kenji Abe; Hirotoshi Kikuchi; Kyoko Kitagawa; Toshiaki Oda; Chiharu Uchida; Masatoshi Kitagawa
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 7.  Targeting the p53 family for cancer therapy: 'big brother' joins the fight.

Authors:  Helen S Bell; Kevin M Ryan
Journal:  Cell Cycle       Date:  2007-06-19       Impact factor: 4.534

Review 8.  The impact of p53 and p73 on aneuploidy and cancer.

Authors:  Richard Tomasini; Tak W Mak; Gerry Melino
Journal:  Trends Cell Biol       Date:  2008-04-10       Impact factor: 20.808

9.  Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379.

Authors:  Christine M Lovly; Ling Yan; Christine E Ryan; Saeko Takada; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

10.  Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.

Authors:  Ian R Logan; Luke Gaughan; Stuart R C McCracken; Vasileia Sapountzi; Hing Y Leung; Craig N Robson
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

View more
  19 in total

1.  Molecular pathways: turning proteasomal protein degradation into a unique treatment approach.

Authors:  Sebastian Stintzing; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2014-04-22       Impact factor: 12.531

2.  High Expression of Pirh2 is Associated with Poor Prognosis in Glioma.

Authors:  Yifeng Bao; Xue Wu; Debin Yuan; Wei Shi; Jinlong Shi
Journal:  Cell Mol Neurobiol       Date:  2017-03-03       Impact factor: 5.046

3.  p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.

Authors:  Yue Ma-Lauer; Javier Carbajo-Lozoya; Marco Y Hein; Marcel A Müller; Wen Deng; Jian Lei; Benjamin Meyer; Yuri Kusov; Brigitte von Brunn; Dev Raj Bairad; Sabine Hünten; Christian Drosten; Heiko Hermeking; Heinrich Leonhardt; Matthias Mann; Rolf Hilgenfeld; Albrecht von Brunn
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-12       Impact factor: 11.205

4.  USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism.

Authors:  Philip A Knobel; Rimma Belotserkovskaya; Yaron Galanty; Christine K Schmidt; Stephen P Jackson; Travis H Stracker
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

Review 5.  Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.

Authors:  Vivien Landré; Barak Rotblat; Sonia Melino; Francesca Bernassola; Gerry Melino
Journal:  Oncotarget       Date:  2014-09-30

6.  Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.

Authors:  Hui Yang; Lin Wu; Shaobo Ke; Wenbo Wang; Lei Yang; Xiaojia Gao; Hongyan Fang; Haijun Yu; Yahua Zhong; Conghua Xie; Fuxiang Zhou; Yunfeng Zhou
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

7.  Further insight into BRUTUS domain composition and functionality.

Authors:  Anna Matthiadis; Terri A Long
Journal:  Plant Signal Behav       Date:  2016-08-02

8.  The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.

Authors:  Alexandra Daks; Alexey Petukhov; Olga Fedorova; Oleg Shuvalov; Alena Kizenko; Elizaveta Tananykina; Elena Vasileva; Oleg Semenov; Andrew Bottrill; Nickolai Barlev
Journal:  Cell Death Dis       Date:  2021-06-05       Impact factor: 8.469

9.  COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth.

Authors:  Hyun Ho Choi; Liem Phan; Ping-Chieh Chou; Chun-Hui Su; Sai-Ching J Yeung; Jiun-Sheng Chen; Mong-Hong Lee
Journal:  Oncotarget       Date:  2015-08-14

10.  Molecular Analysis of the HOXA2-Dependent Degradation of RCHY1.

Authors:  Laure Bridoux; Noémie Deneyer; Isabelle Bergiers; René Rezsohazy
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.